13F Holdings
中文EN

NUTX Nutex Health Inc.

Services-Business Services, NEC · Nasdaq · SEC CIK 1479681 · Fiscal year ends 12/31

Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters

Growth

TTM revenue YoY-18.8%
TTM net income YoY36.5%
TTM EPS YoY20.0%
Revenue 3-yr CAGR50.9%
Net income 3-yr CAGR—

Margins

Gross margin47.8%
Operating margin39.0%
Net margin20.7%
FCF margin31.1%
EBITDA margin41.8%

Returns

ROE43.8%
ROA16.5%
ROIC (approx.)117.4%
Asset turnover0.80x

Leverage & solvency

Liabilities / assets47.6%
Debt / equity0.10x
Current ratio4.76x
Interest coverage16.21x

Cash quality & payout

Operating cash flow / net income1.57x
Accruals ratio-9.4%
Payout ratio—
Capex / revenue1.3%

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item FY20252025-12-31FY20242024-12-31FY20232023-12-31FY20222022-12-31FY20212021-12-31
Income statement
Revenue$875.26M$479.95M$247.65M$219.29M$331.53M
Cost of revenue————$14.65M
Gross profit$444.28M$196.26M$34.77M$15.42M$179.28M
R&D expense————$285,880
SG&A expense$51.65M$41.92M$33.23M$19.81M$5.46M
Operating income$275.62M$130.70M-$31.77M-$406.60M$170.26M
Interest expense$22.23M$19.93M$16.32M$12.49M$6.20M
Pretax income$244.78M$109.83M-$48.49M-$419.65M$169.49M
Income tax$64.42M$15.02M-$5.07M$13.09M$965,731
Net income$70.79M$52.10M-$45.79M-$424.78M$132.59M
EBITDA$296.15M$149.67M-$14.18M-$393.47M$177.93M
EPS (basic)11.1310.23-10.39-100.360.22
EPS (diluted)10.489.69-10.39-100.360.22
Weighted avg. shares (diluted)6.76M5.49M4.41M4.23M—
Balance sheet
Cash & equivalents$185.57M$40.64M$22.00M$34.26M$36.12M
Receivables—$232.45M$58.60M$57.80M$112.77M
Inventory$2.87M$2.85M$3.39M$3.53M$2.81M
Current assets$538.81M$292.48M$90.85M$97.97M$154.02M
PP&E, net$94.58M$77.93M$81.39M$82.09M$151.91M
Goodwill$13.92M$13.92M$17.07M$17.01M$1.14M
Intangibles$21.23M$15.53M$20.51M$21.19M$682,649
Total assets$918.52M$655.32M$398.25M$431.75M$394.65M
Current liabilities$157.91M$154.22M$58.31M$54.86M$37.69M
Short-term debt$13.34M$14.39M$10.81M$12.55M$10.16M
Long-term debt$29.17M$22.47M$26.31M$23.05M$78.82M
Total debt$42.51M$36.86M$37.12M$35.60M$88.98M
Total liabilities$495.09M$466.79M$319.14M$311.42M$203.07M
Shareholders' equity$329.45M$132.44M$61.45M$95.86M$114.65M
Net debt-$143.06M-$3.78M$15.12M$1.34M$52.86M
Shares outstanding7.09M5.51M4.51M4.33M3.95M
Cash flow statement
Operating cash flow$248.12M$23.15M$1.26M$50.61M$173.43M
Capital expenditure$2.53M$2.30M$9.50M$14.63M$36.93M
Free cash flow$245.60M$20.85M-$8.24M$35.97M$136.51M
Investing cash flow-$5.24M-$5.61M-$11.24M-$4.34M-$36.98M
Financing cash flow-$97.95M$1.09M-$2.27M-$48.13M-$125.85M
Depreciation & amortization$20.53M$18.97M$17.59M$13.13M$7.66M
Stock-based compensation$107.78M-$129,743—$189,581$4.03M
Share buybacks$5.00M$0$0——

Free plan shows the latest 5 periods; Pro shows all 16 🔒

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-18 06:30.